Aortic Dissection clinical trials at UCSD

2 research studies open to eligible people

Showing trials for

  • IMPRoving Outcomes in Vascular DisEase- Aortic Dissection

    open to eligible people ages 21 years and up

    The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with surveillance for deterioration in patients with uncomplicated type B aortic dissection.

    San Diego, California and other locations

  • NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

    open to eligible people ages 18 years and up

    Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.

    La Jolla, California and other locations

Our lead scientists for Aortic Dissection research studies include .

Last updated: